Followers | 9 |
Posts | 740 |
Boards Moderated | 0 |
Alias Born | 10/06/2010 |
Thursday, May 22, 2014 2:31:13 AM
SSM's Recent Display at the 11th edition of the North American version of Frankfurt's Techtextil in Atlanta May 13 – 15, 2014. Held in conjunction with the 2nd edition of Texprocess Americas and the composites show JEC Americas, the three filled the Georgia World Congress Center with some 754 exhibitors from 29 countries. -
See more at: http://www.innovationintextiles.com/testing-standards/american-ingenuity-sparkles-at-techtextiltexprocess-na/#sthash.Z6hmlq6j.dpuf
SSM Industries has developed a line of comfortable, light weight, FR-treated cotton knits called Pro-CFR®. The 6.25 oz knit has a 12 cal/cm2 arc rating, while lighter weights offer additional comfort features such as TransDRY® moisture management and antimicrobial technologies. Located in Tennessee, the company is a full service safety and protective fabric manufacturer, with knitting, weaving, dyeing, and finishing under one roof.
Go KBLB
Feb. 13, 2013
Kraig Biocraft Laboratories and SSM Industries Sign Memorandum of Understanding to Jointly Commercialize Recombinant Spider Silk -
The parties caution that while the MOU is a major step toward a binding agreement, it should not be relied upon as a guarantee that a binding agreement will be completed. Kraig Biocraft Laboratories is in discussions with other companies to complete a consortium to drive the penetration of its recombinant spider silks into global markets.
http://globenewswire.com/news-release/2013/02/13/523148/10021633/en/Kraig-Biocraft-Laboratories-and-SSM-Industries-Sign-Memorandum-of-Understanding-to-Jointly-Commercialize-Recombinant-Spider-Silk.html
Everything I say is my own opinion and should not be taken as direct investment advice. Do your own DD and make your own decisions.
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM